Novel Mycobacterium Capture and Concentration from Sputum
- Caryn Tyler
- Oct 13
- 1 min read
Tuberculosis (TB) causes around 1.4 million deaths annually; earlier detection from complex samples like sputum can enable improved patient outcomes and treatment options.(1,2) Traditional methods like culture are slow and labor-intensive. While alternative molecular testing approaches like qPCR and sequencing are faster, they are hindered by inefficient sample preparation methods and the inhibitory nature of the sputum sample matrix.
This study addresses these challenges by using Nanotrap® Microbiome B Particles to enhance Mycobacterium capture and concentration from sputum, offering a novel approach for TB detection.
TECHNICAL NOTE: SKU 65XXX
Literature # WW-TN31420